跳至主要内容
临床试验/NL-OMON48075
NL-OMON48075已完成不适用

The impact of coronary chronic total occlusion percutaneous coronary intervention on culprit vessel physiology - IMPACT-CTO II Study

Basildon and Thurrock University Hospitals0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * > 18 years of age
  • * Willing to participate and able to understand, read and sign the informed
  • consent document before the planned procedure.
  • * Presence of a coronary CTO scheduled for elective PCI
  • * Evidence of viability in the CTO territory
  • * Presence of additional coronary lesions (other than the CTO vessel) in need
  • of FFR/PCI in a second session.

排除标准

  • * < 18 year of age
  • * Unable to give informed consent
  • * Known severe chronic kidney disease (creatinine clearance *30 mL/min),
  • unless the patient is on dialysis
  • * Unable to receive antiplatelets or periprocedural anticoagulation
  • * Any study lesion characteristic resulting in the expected inability to
  • deliver FD-OCT catheter at the distal vessel post CTO PCI (e.g. moderate or
  • severe vessel calcification or tortuosity)
  • * Pregnancy or planning pregnancy during study period

研究者

发起方
Basildon and Thurrock University Hospitals

相似试验